Re: EDIT
I listened to some of Katrine Bosley's presentation at JPM, and it seemed vacuous/amorphous to me. I went into it wondering about taking a small speculative stake in a gene editing company and came away from it wondering if she really believed in the technology.
In her tweet she says she believes in the mission, their accomplishments and most of all the team… she sure doesn't say much about a technology that if it works in humans (big if) could be transformative to humanity if you go down the rabbit hole far enough. I wouldn’t be a comfortable shareholder today…
Dear friends & colleagues,
Five years ago at Editas, we asked the (rather daunting) question, “What if you could repair broken genes?” The journey since then has been intense, exciting, and important. (1/4)
We’ve made great progress towards answering that question, with a lot of changes and transitions along the way. Today, I have news to share of another transition: this time, my own. I’ll soon be stepping down from my role as CEO. (2/4)
As many of you will understand, this was a tough decision. I believe in the mission; in our many unprecedented accomplishments; and, most of all, in the team of Editors we built. I wish them great success – it’s a really important mission. (3/4)
I’m proud of everything we achieved and built together, and I’ll always be cheering them on – now as Editas Emeritas, as we say.
In genome Editas,
Katrine
(4/4)
AI
